UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291

Lung cancer (Amsterdam, Netherlands), 2015-12, Vol.90 (3), p.509-515

2015

Volltextzugriff (PDF)

EGFR Mutation Analysis for Prospective Patient Selection in Two Phase II Registration Studies of Osimertinib

Journal of thoracic oncology, 2017-08, Vol.12 (8), p.1247-1256

2017

Volltextzugriff (PDF)

MA08.03 Osimertinib vs Platinum-Pemetrexed for T790M-Mutation Positive Advanced NSCLC (AURA3): Plasma ctDNA Analysis

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S386-S386

2017

Volltextzugriff (PDF)

Enhancing social values, identity and wellbeing: the impact of participatory working with housing association tenants

Community development journal, 2020-04, Vol.55 (2), p.331-348

2020

Volltextzugriff (PDF)

Human Rabies Prevention — United States, 2008: Recommendations of the Advisory Committee on Immunization Practices

MMWR. Recommendations and reports, 2008-05, Vol.57 (RR-3), p.1-27

2008

Volltextzugriff (PDF)

A genome-wide search for human type 1 diabetes susceptibility genes

Nature (London), 1994-09, Vol.371 (6493), p.130-136

1994

Volltextzugriff (PDF)

Rehabilitating Psychology in Australia: The Journey from Colonising Agent to Cultural Broker

Psychotherapy and politics international, 2015-06, Vol.13 (2), p.115-128

Jenkins, Suzanne

2015

Volltextzugriff (PDF)

Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2017-07, Vol.12 (7), p.1061-1070

2017

Volltextzugriff (PDF)

Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2019-11, Vol.25 (22), p.6644-6652

2019

Volltextzugriff (PDF)

Sequence variants in the melatonin-related receptor gene (GPR50) associate with circulating triglyceride and HDL levels

Journal of lipid research, 2006-04, Vol.47 (4), p.761-766

2006

Volltextzugriff (PDF)

Rehabilitating Psychology in Australia: The Journey from Colonising Agent to Cultural Broker: Rehabilitating Psychology in Australia

Psychotherapy and politics international, 2015-06, Vol.13 (2), p.115-128

Jenkins, Suzanne

2015

Volltextzugriff (PDF)

A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module. Chromosomal localization, frequency analysis, modeling, and expression

The Journal of biological chemistry, 2002-05, Vol.277 (18), p.15354-15362

2002

Volltextzugriff (PDF)

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2018-12, Vol.126, p.133-138

2018

Volltextzugriff (PDF)

A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors

Investigational new drugs, 2023-06, Vol.41 (3), p.493-502

2023

Volltextzugriff (PDF)

Counselling and Storytelling How Did We Get Here?

Psychotherapy and politics international, 2013-06, Vol.11 (2), p.140-151

Jenkins, Suzanne

2013

Volltextzugriff (PDF)

‘Absent fear’: Re-envisioning a future geography

Futures : the journal of policy, planning and futures studies, 2012-06, Vol.44 (5), p.494-503

2012

Volltextzugriff (PDF)

Counselling and Storytelling How Did We Get Here?: Counselling and storytelling

Psychotherapy and politics international, 2013-06, Vol.11 (2), p.140-151

Jenkins, Suzanne

2013

Volltextzugriff (PDF)

P3.02b-021 Comparing T790M Identification across Testing Strategies in Advanced EGFR NSCLC: A Diagnostic Outcomes and Cost Analysis: Topic: EGFR Biomarkers

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1198-S1199

2017

Volltextzugriff (PDF)

P3.02b-021 Comparing T790M Identification across Testing Strategies in Advanced EGFR NSCLC: A Diagnostic Outcomes and Cost Analysis

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1198-S1199

2017

Volltextzugriff (PDF)

Outbreak of Legionnaires' disease associated with a display whirlpool spa

International journal of epidemiology, 2000-12, Vol.29 (6), p.1092-1098

2000

Volltextzugriff (PDF)

EGFR T790M mutation testing within the osimertinib AURA Phase I study

Lung cancer (Amsterdam, Netherlands), 2017-07, Vol.109, p.9-13

2017

Volltextzugriff (PDF)

A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors

Targeted oncology, 2023-07, Vol.18 (4), p.517-530

2023

Volltextzugriff (PDF)

EGFR T790M mutation testing within a phase I study with AZD9291

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19051-e19051

2014

Volltextzugriff (PDF)

1 – 25 von 369

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(290)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer

EGFR Mutation Analysis for Prospective Patient Selection in Two Phase II Registration Studies of Osimertinib

MA08.03 Osimertinib vs Platinum-Pemetrexed for T790M-Mutation Positive Advanced NSCLC (AURA3): Plasma ctDNA Analysis

Enhancing social values, identity and wellbeing: the impact of participatory working with housing association tenants

Human Rabies Prevention — United States, 2008: Recommendations of the Advisory Committee on Immunization Practices

A genome-wide search for human type 1 diabetes susceptibility genes

Rehabilitating Psychology in Australia: The Journey from Colonising Agent to Cultural Broker

Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer

Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

Sequence variants in the melatonin-related receptor gene (GPR50) associate with circulating triglyceride and HDL levels

Rehabilitating Psychology in Australia: The Journey from Colonising Agent to Cultural Broker: Rehabilitating Psychology in Australia

A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module. Chromosomal localization, frequency analysis, modeling, and expression

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors

Counselling and Storytelling How Did We Get Here?

‘Absent fear’: Re-envisioning a future geography

Counselling and Storytelling How Did We Get Here?: Counselling and storytelling

P3.02b-021 Comparing T790M Identification across Testing Strategies in Advanced EGFR NSCLC: A Diagnostic Outcomes and Cost Analysis: Topic: EGFR Biomarkers

P3.02b-021 Comparing T790M Identification across Testing Strategies in Advanced EGFR NSCLC: A Diagnostic Outcomes and Cost Analysis

Outbreak of Legionnaires' disease associated with a display whirlpool spa

EGFR T790M mutation testing within the osimertinib AURA Phase I study

A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors

EGFR T790M mutation testing within a phase I study with AZD9291

Suchergebnisse filtern